Bausch & Lomb CORP Form 4 insider transactions

Barbara Trebbi, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Laurence E Paul, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Robert J Chersi, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp, sold 52,900 shares of common stock on August 10, 2026 for $16.78 per share.

Eschenbach Andrew C. Von, a Director of Bausch & Lomb Corp, sold 18,559 shares of common stock on August 6, 2026.

Andrew J. Stewart, President, GPIC of Bausch & Lomb Corp, received 16,778 shares of common stock on August 5, 2026.

Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp, received 9,091 shares of common stock on August 5, 2026.

Yehia Hashad, EVP of R&D and CMO of Bausch & Lomb Corp, received 20,973 shares of common stock on August 5, 2026.

Sam Eldessouky, EVP and CFO of Bausch & Lomb Corp, received 50,335 shares of common stock on August 5, 2026.

Luc Bonnefoy, President, Surgical of Bausch & Lomb Corp, received 16,778 shares of common stock on August 5, 2026.

A Robert D Bailey, EVP & Chief Legal Officer of Bausch & Lomb Corp, received 33,557 shares of common stock on August 5, 2026.

Brent L Saunders, Chairman of the Board and CEO and a Director of Bausch & Lomb Corp, reported multiple transactions in common stock on August 5, 2026.

Luc Bonnefoy, President of Surgical at Bausch & Lomb Corp, reported a transaction involving common shares on June 12, 2026.

Director Andrew C. von Eschenbach received an annual grant of 15,842 restricted share units in Bausch + Lomb Corporation.

Director Thomas W. Ross Sr. acquired 15,842 restricted share units as part of an annual compensation grant.

Director Russel C. Robertson acquired 15,842 common shares of Bausch + Lomb Corporation via an annual RSU grant.

Director John Paulson acquired 15,842 common shares of Bausch + Lomb Corporation through an annual RSU grant.

Director Karen Ling acquired 15,842 restricted share units of Bausch + Lomb Corporation as part of an annual director compensation grant.

Director Sarah B. Kavanagh acquired 15,842 common shares of Bausch + Lomb Corporation through an annual restricted share unit grant.

Director Steven H. Collis acquired 15,842 common shares of Bausch + Lomb Corporation via an annual restricted share unit grant.

Director Nathalie D. Bernier acquired 15,842 common shares of Bausch + Lomb Corporation via an annual RSU grant.

Director Eduardo Alfonso acquired 15,842 restricted share units in Bausch + Lomb Corporation as part of an annual equity grant.

Bausch & Lomb Corp. Chairman and CEO Brent L. Saunders reported a disposition of company shares on May 22, 2026.

EVP and CFO Sam Eldessouky of Bausch & Lomb Corp. reported a transaction involving common shares.

Yehia Hashad, EVP of R&D and CMO at Bausch & Lomb Corp, reported a transaction involving the withholding of common shares to cover tax obligations upon the vesting of restricted share units.

Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp, reported a disposition of 8,673 common shares on May 5, 2026, to cover tax withholding obligations upon vesting of restricted share units.

Luc Bonnefoy, President of Surgical at Bausch & Lomb Corp, reported a transaction involving the withholding of common shares for tax obligations.

Director Russel C. Robertson acquired 1,611 restricted share units of Bausch + Lomb Corporation on April 30, 2026.

Director John Paulson acquired 1,375 restricted share units of Bausch + Lomb Corporation at a price of $15.90 per share.

Director Steven H. Collis acquired 1,415 restricted share units of Bausch + Lomb Corporation on April 30, 2026.